Agrenvec is a company that commercializes recombinant proteins and antibodies for the research and development market. It provides a range of products with a focus on cancer, cell biology, immunology, neurobiology, cardiovascular, and other research areas. In addition, the company offers polyclonal antibody and recombinant protein production services.